CancerNCT07872956
Feasibility Study of a Co-Designed Gamified Medical Yoga App for Home-Based Cancer Rehabilitation
A study testing Medical yoga in people with Cancer, run by Linkoeping University at 1 site in Sweden.
Trial summary
The project aims to develop a gamified medical yoga intervention through co-design with patients with cancer and key stakeholders, ensuring alignment with user needs and requirements. The first objective is to identify user and stakeholder needs, preferences, and requirements for effective home-based training. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Cancer
- What is being tested?
- Medical yoga
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 10 participants
- Where
- 1 siteSweden
- Study dates
- 1 Sep 2026to 31 Dec 2028
- Phase
- Interventional
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Diagnosed with cancer
- Undergoing oncological treatment
- Speaking swedish.
Who cannot join
- severe cognitive impairment
- physical limitations preventing yoga practice
- anticipated survival of less than three months.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Sweden1 site, 1 recruiting
- Recruiting
Linköping comprehensive cancer center
Linköping
Anna-Karin Ax, PHd, +46- 0101039360, anna-karin.ax@regionostergotland.se
About this study
Official title: Co-Designing and Testing the Feasibility of a Gamified AI Medical Yoga App for Home-Based Cancer Rehabilitation
The project aims to develop a gamified medical yoga intervention through co-design with patients with cancer and key stakeholders, ensuring alignment with user needs and requirements. The first objective is to identify user and stakeholder needs, preferences, and requirements for effective home-based training. The project will then examine facilitators and barriers that influence patient engagement with gamification interventions. Subsequently, it will assess the feasibility, acceptability, including usability and acceptability, of the gamified AI yoga intervention for patients with cancer in real-world implementation contexts.
- Conditions
- Cancer
- Being tested
- Medical yoga
- Keywords
- cancer, e-health, yoga, rehabilitation, app
- Medical subject headings
- Neoplasms, Alzheimer Disease
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Medical yogaDevice
Feasability testina a gamified yoga application for 2 months
| Study group | Role | What they receive |
|---|---|---|
| Yoga application | Experimental | Feasability of using a yoga application for 2 months Receives: Device: Medical yoga |
What is being measured
The primary outcome is the main question the study is designed to answer.
Device feasability
Acceptability and usabilitywill be explored through semi-structured interviews. Interview data will be analyzed using qualitative content analysis to identify themes related to participants' experiences, perceived benefits, barriers, and suggestions for improvement.
Measured: from enrollment and after 8 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Oct 2026
- Study start1 Sep 2026
- Primary completion31 Dec 2028 (estimated)
- Study completion31 Dec 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for CancerStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Device feasibility
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 10 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Linkoeping University
- Sponsor type
- Other government
- Responsible party
- Principal investigator, Anna-Karin Ax, Linkoeping University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07872956
- Sponsor's protocol ID
- Dnr 2026-03378-01
- Status last verified
- Jun 2026
- First submitted
- 12 Aug 2026
- Last updated
- 14 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No